Connection

Announcement

You can now add alternative names! Click here to add other names that you've published under.

Search Results to Shmuel Yaccoby

This is a "connection" page, showing the details of why an item matched the keywords from your search.

Search Results

Yaccoby, Shmuel

One or more keywords matched the following items that are connected to Yaccoby, Shmuel

Item Type	Name
Academic Article	Inhibitory effects of osteoblasts and increased bone formation on myeloma in novel culture systems and a myelomatous mouse model.
Academic Article	Establishment and exploitation of hyperdiploid and non-hyperdiploid human myeloma cell lines.
Academic Article	Fibroblast activation protein (FAP) is upregulated in myelomatous bone and supports myeloma cell survival.
Academic Article	Targeting beta2-microglobulin for induction of tumor apoptosis in human hematological malignancies.
Academic Article	Human placenta-derived adherent cells prevent bone loss, stimulate bone formation, and suppress growth of multiple myeloma in bone.
Academic Article	Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivo.
Academic Article	Role of Bruton's tyrosine kinase in myeloma cell migration and induction of bone disease.
Academic Article	Highly activated and expanded natural killer cells for multiple myeloma immunotherapy.
Academic Article	Atacicept (TACI-Ig) inhibits growth of TACI(high) primary myeloma cells in SCID-hu mice and in coculture with osteoclasts.
Academic Article	The SCID-rab model: a novel in vivo system for primary human myeloma demonstrating growth of CD138-expressing malignant cells.
Academic Article	Wnt3a signaling within bone inhibits multiple myeloma bone disease and tumor growth.
Academic Article	Soluble syndecan-1 promotes growth of myeloma tumors in vivo.
Academic Article	Therapeutic effects of intrabone and systemic mesenchymal stem cell cytotherapy on myeloma bone disease and tumor growth.
Academic Article	The SCID-hu myeloma model.
Academic Article	Inhibitor of DASH proteases affects expression of adhesion molecules in osteoclasts and reduces myeloma growth and bone disease.
Academic Article	The proliferative potential of myeloma plasma cells manifest in the SCID-hu host.
Academic Article	The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapy.
Academic Article	The ephrinB2/EphB4 axis is dysregulated in osteoprogenitors from myeloma patients and its activation affects myeloma bone disease and tumor growth.
Academic Article	Consequences of daily administered parathyroid hormone on myeloma growth, bone disease, and molecular profiling of whole myelomatous bone.
Academic Article	Repression of multiple myeloma growth and preservation of bone with combined radiotherapy and anti-angiogenic agent.
Academic Article	Syndecan-1 is targeted to the uropods of polarized myeloma cells where it promotes adhesion and sequesters heparin-binding proteins.
Academic Article	NAMPT/PBEF1 enzymatic activity is indispensable for myeloma cell growth and osteoclast activity.
Academic Article	The proteasome inhibitor, bortezomib suppresses primary myeloma and stimulates bone formation in myelomatous and nonmyelomatous bones in vivo.
Academic Article	Primary myeloma cells growing in SCID-hu mice: a model for studying the biology and treatment of myeloma and its manifestations.
Academic Article	Multiple myeloma disrupts the TRANCE/ osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression.
Academic Article	Combinatorial efficacy of anti-CS1 monoclonal antibody elotuzumab (HuLuc63) and bortezomib against multiple myeloma.
Concept	Mice, Inbred ICR
Concept	Mice, Inbred C57BL
Concept	Mice, Inbred BALB C
Concept	Mice, Transgenic
Concept	Mice, Inbred NOD
Concept	Mice
Concept	Mice, SCID
Academic Article	Role of Bruton's tyrosine kinase (BTK) in growth and metastasis of INA6 myeloma cells.
Academic Article	CYR61/CCN1 overexpression in the myeloma microenvironment is associated with superior survival and reduced bone disease.
Academic Article	A peptide nucleic acid targeting nuclear RAD51 sensitizes multiple myeloma cells to melphalan treatment.
Academic Article	A Cyclin-Dependent Kinase Inhibitor, Dinaciclib, Impairs Homologous Recombination and Sensitizes Multiple Myeloma Cells to PARP Inhibition.
Grant	Myeloma-Microenvironment Interaction Dynamics
Grant	Effect of TACI-lg and BAFFR-lg on primary myeloma growth in SCID-hu mice
Grant	Inhibition of primary myeloma by Thrombospondin-1 Peptide Mimetic in vivo
Grant	Effect of TACI-lg and BAFFR-lg on primary myeloma growth in SCID-hu mice

Search Criteria

Mice